Forest Acquires U.S. Rights To Nycomed's Oral COPD Drug Daxas

After long development haul, PDE-4 inhibitor finally gets adopted by a commercial parent, ahead of approval.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet